[ET Net News Agency, 15 April 2024] HIGHTIDE-B (02511) rose 13.7% to HK$4.89.
It hits an intra-day high of HK$4.89, and an intra-day low of HK$4.03. The total shares
traded was 641,000, with a value of HK$2.87m. The active buy/sell ratio is 72:28, with net
buying turnover of HK$1.26m. MORGAN STANLEY HK SEC accounts for greatest net responsive
buying turnover of HK$32,075, with volume weighted average price of HK$4.257. CHINA INV
INFO accounts for greatest net responsive selling turnover of HK$150,963, with volume
weighted average price of HK$4.473. The stock has risen a combined 15.1% over the past 2
consecutive trading days.
Basic Information
=================
-----------------------------------
Nominal 4.890 % Chg +13.72%
High 4.890 Low 4.030
Shares Tr 641,000 Turnover 2.87m
10-D SMA 5.210 %H.V 114.493
20-D SMA 5.916 VWAP 4.477
50-D SMA 8.797 RSI14 30.280
-----------------------------------
Status: Active buy/sell ratio is 72:28, with net buying turnover of HK$1.26m, rising a
combined 15.1% over the past 2 consecutive trading days
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
---------------------------------------------
HIGHTIDE-B (02511) 4.89 +13.72
GENSCRIPT BIO (01548) 12.16 -4.70
INNOVENT BIO (01801) 35.75 -4.28
EVEREST MED-B (01952) 24.65 -5.74
LAEKNA-B (02105) 7.83 +62.79
WUXI BIO (02269) 13.66 -1.73
TIGERMED (03347) 32.40 +0.47
BEIGENE (06160) 83.05 -3.09
AKESO (09926) 48.10 -2.83
REMEGEN (09995) 29.10 -9.77
---------------------------------------------
(ed)